Plasma Methionine Enkephalin. Increased Levels During a Migraine Episode
Authors:
- 22 June 1986
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 26 (6) , 278-281
Abstract
SYNOPSIS Plasma methionine‐enkephalin (MET) levels in migraine patients, either during an attack or when pain‐free, are statistically significantly higher than in matched controls; this is also true when comparing the classical and nonclassical migraine subpopulations with the control group. Individual patients consistently presented lower MET plasma concentrations in the pain‐free period than during the acute headache, with some subjects showing values falling within the range of controls. Platelet neuropeptide content was similar in patients and controls, irrespective of plasma MET levels. These results indicate that increased plasma MET concentrations are associated with the occurrence of a migraine episode and suggests that they are not a constant characteristic of migraineurs.Keywords
This publication has 5 references indexed in Scilit:
- Plasma Methionine Enkephalin Levels — A Biological Marker for Migraine?Headache: The Journal of Head and Face Pain, 1985
- Progressive impairment of CSF β-EP levels in migraine sufferersPain, 1984
- Enkephalin-binding systems in human plasmaNeurochemical Research, 1983
- Neuropeptide degrading enzyme(s) in plasma and brain: Effects of in vivo neuroleptic administrationPharmacological Research Communications, 1982
- Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cellsNature, 1981